Therapeutic Asset Ratings
3,272 results matching 1 filter
91,583 assets · 7,906 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
VEMURAFENIB
Rhabdomyosarcoma
National Cancer Institute (NCI)
P2
CCC
(55)
VEMURAFENIB
Neuroblastoma
National Cancer Institute (NCI)
P2
CCC
(55)
VEMURAFENIB
Rhabdoid Tumor
National Cancer Institute (NCI)
P2
CCC
(55)
VEMURAFENIB
Wilms Tumor
National Cancer Institute (NCI)
P2
CCC
(55)
Venetoclax
Acute Leukemia Of Ambiguous Lineage
National Cancer Institute (NCI)
P2
CCC
(55)
CIS-DIAMMINEDICHLOROPLATINUM II
Cervical Carcinoma
National Cancer Institute (NCI)
P1
CCC
(55)
Azacitidine
Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma Of The Elderly
National Cancer Institute (NCI)
P2/3
CCC
(55)
Azacitidine
High Grade B-Cell Lymphoma
National Cancer Institute (NCI)
P2/3
CCC
(55)
Azacitidine
High Grade B-Cell Lymphoma With MYC And/ Or BCL2 And/Or BCL6 Rearrangement
National Cancer Institute (NCI)
P2/3
CCC
(55)
Azacitidine
T-Cell/Histiocyte Rich Large B Cell Lymphoma
National Cancer Institute (NCI)
P2/3
CCC
(55)
IMMUNOTHERAPIC BIFUNCTIONAL FUSION PROTEIN COMPRISED OF A FULLY HUMAN IGG1 MONOCLONAL ANTIBODY (AVELUMAB) AGAINST HUMAN PROGRAMMED DEATH-LIGAND 1 (PD-L1) FUSED TO THE SOLUBLE EXTRACELLULAR DOMAIN OF TRANSFORMING GROWTH FACTOR-.BETA. (TGF-.BETA.) RECEPTOR II, WHICH ACTS AS A TGF-.BETA. TRAP
Reproductive System Cancer
National Cancer Institute (NCI)
P1/2
CCC
(55)
PREDNISONE TABLETS
Cutaneous Melanoma
National Cancer Institute (NCI)
P1/2
CCC
(55)
Recombinant Human Hyaluronidase
Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma Of The Elderly
National Cancer Institute (NCI)
P2/3
CCC
(55)
Recombinant Human Hyaluronidase
High Grade B-Cell Lymphoma With MYC And/ Or BCL2 And/Or BCL6 Rearrangement
National Cancer Institute (NCI)
P2/3
CCC
(55)
Recombinant Human Hyaluronidase
Lymphoplasmacytic Lymphoma
National Cancer Institute (NCI)
P2/3
CCC
(55)
Recombinant Human Hyaluronidase
T-Cell/Histiocyte Rich Large B Cell Lymphoma
National Cancer Institute (NCI)
P2/3
CCC
(55)
Sirolimus
Cutaneous Melanoma
National Cancer Institute (NCI)
P1/2
CCC
(55)
Venetoclax
Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma Of The Elderly
National Cancer Institute (NCI)
P2/3
CCC
(55)
(+)-VINCRISTINE
B-Cell Neoplasm
National Cancer Institute (NCI)
P1/2
CCC
(55)
Sodium Thiosulfate
Colorectal Cancer
National Cancer Institute (NCI)
P3
CCC
(54)
Adavosertib
Metastatic Malignant Neoplasm
National Cancer Institute (NCI)
P2
CCC
(54)
Alpelisib
Her2-Receptor Negative Breast Cancer
National Cancer Institute (NCI)
P2
CCC
(54)
CHLOROPTIC-P S.O.P. COMPONENT PREDNISOLONE
Acute Leukemia Of Ambiguous Lineage
National Cancer Institute (NCI)
P2
CCC
(54)
DENTALFLUORO
Prostate Neoplasm
National Cancer Institute (NCI)
P2
CCC
(54)
DIPHENHYDRAMINE
Mantle Cell Lymphoma
National Cancer Institute (NCI)
P2
CCC
(54)
Showing 951 to 975 of 3,272 assets
Previous
Page 39 of 131
Next